Clinical Trial Update: Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating different doses of anti-thymocyte globulin to treat children with severe aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Severe Aplastic Anemia | Phase 4 | Status: UNKNOWN